RESUMO
Neurodegenerative disorders are frequent, incurable diseases characterised by abnormal protein accumulation and progressive neuronal loss. Despite their growing prevalence, the underlying pathomechanism remains unclear. Lemur tyrosine kinase 2 (LMTK2) is a member of a transmembrane serine/threonine-protein kinase family. Although it was described more than a decade ago, our knowledge on LMTK2's biological functions is still insufficient. Recent evidence has suggested that LMTK2 is implicated in neurodegeneration. After reviewing the literature, we identified three LMTK2-mediated mechanisms which may contribute to neurodegenerative processes: disrupted axonal transport, tau hyperphosphorylation and enhanced apoptosis. Moreover, LMTK2 gene expression is decreased in an Alzheimer's disease mouse model. According to these features, LMTK2 might be a promising therapeutic target in near future. However, further investigations are required to clarify the exact biological functions of this unique protein.
Assuntos
Degeneração Neural/enzimologia , Proteínas Serina-Treonina Quinases/metabolismo , Animais , Apoptose , Transporte Axonal , Humanos , Modelos Biológicos , Ligação ProteicaAssuntos
Antagonistas de Androgênios/uso terapêutico , Antineoplásicos Hormonais/uso terapêutico , Biomarcadores Tumorais/sangue , Detecção Precoce de Câncer , Programas de Rastreamento , Antígeno Prostático Específico/sangue , Prostatectomia , Neoplasias da Próstata/mortalidade , Conduta Expectante , Humanos , MasculinoRESUMO
Major clinical trials using prostate-specific antigen (PSA) as the screening test to detect localized early-stage prostate cancer and to attempt to change its natural history with early intervention have yielded conflicting interpretations. The US Prostate, Lung, Colorectal, and Ovarian (US PLCO) cancer screening trial concluded that PSA-based screening conferred no meaningful survival benefit, whereas the European Randomized Study of Screening for Prostate Cancer (ERSPC) and the GOTEBORG clinical trial (GOTEBORG) trials claimed statistically significant life-saving benefits. These divergent outcomes have not provided physicians with clarity on the best evidence-based treatment. To determine the extent to which these divergent outcomes are clinically meaningful, we evaluated these data and those of a long-term prospective cohort study in the context of the clinically documented harms of androgen deprivation therapy (ADT). We noted the unheralded fact that in both European trials far more patients received hormonal treatment in the control than the prostatectomy arm, whereas hormonal therapy in the US trial was balanced between arms. We examined this imbalance in ADT treatment and prostate cancer-related deaths in the contexts of contamination, stage migration, and attribution of cause of death, all of which impinge on data interpretation. The ERSPC and GOTEBORG data are compatible with the hypothesis that ADT treatment contributes differentially to an increase in prostate cancer deaths in control patients. If so, the claim of a reduction in prostate cancer deaths in the screened cohort requires reappraisal. The conventional interpretation that PSA screening and radical treatment intervention are the major contributors to the results of these two studies needs more rigorous scientific scrutiny, as does the role of ADT treatment of nonmetastatic disease.
Assuntos
Antagonistas de Androgênios/uso terapêutico , Antineoplásicos Hormonais/uso terapêutico , Biomarcadores Tumorais/sangue , Detecção Precoce de Câncer , Programas de Rastreamento , Antígeno Prostático Específico/sangue , Prostatectomia , Neoplasias da Próstata/mortalidade , Conduta Expectante , Antagonistas de Androgênios/efeitos adversos , Antineoplásicos Hormonais/efeitos adversos , Ensaios Clínicos como Assunto , Europa (Continente)/epidemiologia , Medicina Baseada em Evidências , Humanos , Masculino , Estadiamento de Neoplasias , Valor Preditivo dos Testes , Neoplasias da Próstata/diagnóstico , Neoplasias da Próstata/tratamento farmacológico , Neoplasias da Próstata/imunologia , Neoplasias da Próstata/patologia , Neoplasias da Próstata/cirurgia , Radioterapia Adjuvante , Viés de Seleção , Estados Unidos/epidemiologia , Conduta Expectante/estatística & dados numéricosAssuntos
Antineoplásicos/uso terapêutico , Ensaios Clínicos Fase III como Assunto , Aprovação de Drogas , Auditoria Médica , Neoplasias/tratamento farmacológico , Antineoplásicos/efeitos adversos , Antineoplásicos/farmacologia , Austrália , Intervalo Livre de Doença , Feminino , Humanos , Masculino , Notificação de Abuso , Neoplasias/mortalidade , Neoplasias/patologia , Publicações Periódicas como Assunto/normas , Publicações Periódicas como Assunto/tendências , Medição de Risco , Análise de Sobrevida , Fatores de TempoRESUMO
A 2010 Nature editorial entitled "Time for the Epigenome" trumpets the appearance of the International Human Epigenome Consortium and likens it to Biology's equivalent of the Large Hadron Collider. It strongly endorses the viewpoint that selective modifications of "marks" on DNA and histones constitute the crucial codes of life, a proposition which is hotly contested (Ptashne et al., in 2010). This proposition reflects the current mindset that DNA and histone modifications are the prime movers in gene regulation during evolution. This claim is perplexing, since the well characterized organisms, Drosophila melanogaster and Caenorhabditis elegans, lack methylated DNA "marks" and the DNA methytransferase enzymology. Despite their complete absence, D. melanogaster nevertheless has extensive gene regulatory networks which drive sophisticated development, gastrulation, migration of germ cells and yield a nervous system with significant neural attributes. In stark contrast, the honey bee Apis mellifera deploys its human-type DNA methyltransferase enzymology to "mark" its DNA and it too has sophisticated development. What roles therefore is DNA methylation playing in different animals? The honey bee brings a fresh perspective to this question. Its combinatorial chemistry of pheromones, tergal and cuticular exudates provide an exquisite communication system between thousands of individuals. The development of queen and worker is strictly controlled by differential feeding of royal jelly and their adult behaviors are accompanied by epigenomic changes. Their interfaces with different "environments" are extensive, allowing an evaluation of the roles of epigenomes in behavior in a natural environment, in the space of a few weeks, and at requisite levels of experimental rigor.
Assuntos
Comportamento/fisiologia , Epigênese Genética , Animais , Abelhas , Encéfalo/metabolismo , Metilação de DNA , Regulação da Expressão Gênica , Humanos , Feromônios/fisiologiaAssuntos
Proteínas de Ligação ao Cálcio/história , Correspondência como Assunto/história , Flavonoides/história , Transportadores de Ânions Orgânicos/história , Livros de Texto como Assunto/história , Proteínas de Ligação ao Cálcio/farmacologia , Flavonoides/farmacologia , História do Século XX , Humanos , Hungria , Idioma , Transportadores de Ânions Orgânicos/farmacologiaAssuntos
Biomarcadores Tumorais/genética , Mapeamento Cromossômico/economia , Análise Mutacional de DNA/economia , Terapia Genética , Genoma Humano , Projeto Genoma Humano/organização & administração , Neoplasias/genética , Mapeamento Cromossômico/métodos , Análise Mutacional de DNA/métodos , HumanosAssuntos
Dermatite , Modelos Animais de Doenças , Diterpenos , Inflamação , Irritantes/toxicidade , Modelos Animais , Otite Externa/induzido quimicamente , Alcinos/administração & dosagem , Alcinos/toxicidade , Animais , Antralina/administração & dosagem , Antralina/toxicidade , Ácido Araquidônico/administração & dosagem , Ácido Araquidônico/toxicidade , Cantaridina/administração & dosagem , Cantaridina/toxicidade , Capsaicina/administração & dosagem , Capsaicina/toxicidade , Carragenina/administração & dosagem , Carragenina/toxicidade , Óleo de Cróton/administração & dosagem , Óleo de Cróton/toxicidade , Edema/induzido quimicamente , Pé , Irritantes/administração & dosagem , Masculino , Camundongos , Mostardeira , Extratos Vegetais/administração & dosagem , Extratos Vegetais/toxicidade , Óleos de Plantas , Ratos , Reprodutibilidade dos Testes , Terpenos/administração & dosagem , Terpenos/toxicidade , Acetato de Tetradecanoilforbol/administração & dosagem , Acetato de Tetradecanoilforbol/toxicidade , Zimosan/administração & dosagem , Zimosan/toxicidadeRESUMO
A 2.91-billion base pair (bp) consensus sequence of the euchromatic portion of the human genome was generated by the whole-genome shotgun sequencing method. The 14.8-billion bp DNA sequence was generated over 9 months from 27,271,853 high-quality sequence reads (5.11-fold coverage of the genome) from both ends of plasmid clones made from the DNA of five individuals. Two assembly strategies-a whole-genome assembly and a regional chromosome assembly-were used, each combining sequence data from Celera and the publicly funded genome effort. The public data were shredded into 550-bp segments to create a 2.9-fold coverage of those genome regions that had been sequenced, without including biases inherent in the cloning and assembly procedure used by the publicly funded group. This brought the effective coverage in the assemblies to eightfold, reducing the number and size of gaps in the final assembly over what would be obtained with 5.11-fold coverage. The two assembly strategies yielded very similar results that largely agree with independent mapping data. The assemblies effectively cover the euchromatic regions of the human chromosomes. More than 90% of the genome is in scaffold assemblies of 100,000 bp or more, and 25% of the genome is in scaffolds of 10 million bp or larger. Analysis of the genome sequence revealed 26,588 protein-encoding transcripts for which there was strong corroborating evidence and an additional approximately 12,000 computationally derived genes with mouse matches or other weak supporting evidence. Although gene-dense clusters are obvious, almost half the genes are dispersed in low G+C sequence separated by large tracts of apparently noncoding sequence. Only 1.1% of the genome is spanned by exons, whereas 24% is in introns, with 75% of the genome being intergenic DNA. Duplications of segmental blocks, ranging in size up to chromosomal lengths, are abundant throughout the genome and reveal a complex evolutionary history. Comparative genomic analysis indicates vertebrate expansions of genes associated with neuronal function, with tissue-specific developmental regulation, and with the hemostasis and immune systems. DNA sequence comparisons between the consensus sequence and publicly funded genome data provided locations of 2.1 million single-nucleotide polymorphisms (SNPs). A random pair of human haploid genomes differed at a rate of 1 bp per 1250 on average, but there was marked heterogeneity in the level of polymorphism across the genome. Less than 1% of all SNPs resulted in variation in proteins, but the task of determining which SNPs have functional consequences remains an open challenge.
Assuntos
Genoma Humano , Projeto Genoma Humano , Análise de Sequência de DNA , Algoritmos , Animais , Bandeamento Cromossômico , Mapeamento Cromossômico , Cromossomos Artificiais Bacterianos , Biologia Computacional , Sequência Consenso , Ilhas de CpG , DNA Intergênico , Bases de Dados Factuais , Evolução Molecular , Éxons , Feminino , Duplicação Gênica , Genes , Variação Genética , Humanos , Íntrons , Masculino , Fenótipo , Mapeamento Físico do Cromossomo , Polimorfismo de Nucleotídeo Único , Proteínas/genética , Proteínas/fisiologia , Pseudogenes , Sequências Repetitivas de Ácido Nucleico , Retroelementos , Análise de Sequência de DNA/métodos , Especificidade da EspécieRESUMO
A comparative analysis of the genomes of Drosophila melanogaster, Caenorhabditis elegans, and Saccharomyces cerevisiae-and the proteins they are predicted to encode-was undertaken in the context of cellular, developmental, and evolutionary processes. The nonredundant protein sets of flies and worms are similar in size and are only twice that of yeast, but different gene families are expanded in each genome, and the multidomain proteins and signaling pathways of the fly and worm are far more complex than those of yeast. The fly has orthologs to 177 of the 289 human disease genes examined and provides the foundation for rapid analysis of some of the basic processes involved in human disease.